Furthermore, these results might inform autoimmune diseases dependent on JAK-STAT signaling (e.g. rheumatoid arthritis or psoriasis) or other malignancies, such as breast cancer, where the potential direct metabolic effects of SERMs might be underestimated. The gene discussed is SOAT1; the disease is rheumatoid arthritis.